Lv2
140 积分 2025-10-10 加入
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Genome-Wide Screens Reveal Potential Biomarkers of NK-cell Sensitivity
4个月前
已完结
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
7个月前
已完结
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
9个月前
已完结
皖公网安备34019202002308
